Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An international sleep study has found that insomnia, anxiety, and depression were very prevalent during the first wave of the COVID-19 pandemic. Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.

An alarm clock showing 3AM next to a sleeping woman who seems unable to sleep

The COVID-19 pandemic brought changes to the way people work, socialise and spend leisure time. It also brought stressors in the form of health concerns, social isolation, financial hardship, home-schooling, and uncertainty about the future. All of this combined has had a major impact on sleep and psychological well-being.

In June 2020, an international group of researchers led by Professor Colin Espie from the Nuffield Department of Clinical Neurosciences at the University of Oxford and Professor Charles Morin, Department of Psychology, Laval University Director set out to investigate the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.

This study documented the prevalence of clinical cases of insomnia, anxiety, and depression and selected risk factors (COVID-19, confinement, financial burden, social isolation) during the first wave of the pandemic from May to August 2020. Over 22,000 adults from 13 countries across four continents completed a web-based survey about their sleep and psychological symptoms.

Read the full story on the University of Oxford website

Similar stories

EAVI2020: The Quest for an HIV Vaccine

In this long read published to coincide with International AIDS Day, we explore how an international collaboration – of which the University of Oxford is a key partner – has boosted HIV vaccine research. We thank our partners at Imperial College London for allowing us to reproduce and abridge this article.

New SMRU building opened in Thailand to provide health care to marginalized populations

The inauguration of a new joint Shoklo Malaria Research Unit (SMRU) and Borderland Health Foundation (BHF) Building took place in Mae Ramat, Thailand, this week.

Smoking increases the risks of 56 diseases in Chinese adults

Smoking increases the risks of 56 diseases and kills more than one million adults in China each year from 22 different causes, according to new research published in The Lancet Public Health.

Success for Oxford researchers in The Genetics Society 2023 Awards

Researchers from Department of Physiology, Anatomy and Genetics, Radcliffe Department of Medicine and Nuffield Department of Population Health have been recgonised in The Genetics Society 2023 awards.

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.